Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 7, 2012
A Phase 2 clinical trial to evaluate the activity of imetelstat (GRN163L) in patients with essential thrombocythemia or polycythemia vera who require cytoreduction and have failed or are intolerant to previous therapy, or who refuse standard therapy.